Susquehanna International Group, LLP Galectin Therapeutics Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.04 - $2.86 $32,028 - $44,902
15,700 New
15,700 $43,000
Q4 2022

Feb 14, 2023
SELL
$1.03 - $1.66 $51,397 - $82,834
-49,900 Reduced 67.71%
23,800 $26,000
Q3 2022

Nov 14, 2022
BUY
$1.31 - $2.48 $39,824 - $75,392
30,400 Added 70.21%
73,700 $120,000

Others Institutions Holding GALT

# of Institutions
90
Shares Held
9.44M
Call Options Held
1.16M
Put Options Held
1.98M
View Full List

About GALECTIN THERAPEUTICS INC

GALT Quotes by TradingView
  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $158M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email